Biolife Solutions Overview
Valuation check: BLFS's P/E ratio is 35.48, above the Healthcare sector average of 25.3.
Get informed when a big investor buys or sells
+ Follow35.48
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
Biolife Solutions (BLFS) currently reports a P/E ratio of 35.48. That is above the Healthcare sector average of 25.3. Use the charts on this page to explore Biolife Solutions's P/E ratio history and peer comparisons.
Biolife Solutions's P/E ratio of 35.48 is higher than the Healthcare sector average of 25.3. That is roughly 40.3% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The P/E ratio is a valuation multiple that relates Biolife Solutions's market price to a fundamental measure such as earnings, sales, or book value. At 35.48, BLFS can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current P/E ratio of 35.48, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 25.3. From there, open related valuation or income-statement pages for Biolife Solutions, and consider following BLFS for alerts when major investors trade the stock.
Biolife Solutions is classified in the Healthcare sector. On P/E ratio, it currently shows 35.48 versus a sector average near 25.3. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BLFS with unrelated industries.
